Kexin Xu

UT Health Science Center Houston

NIH Rank #15004
  • R01 Holder
  • Translational
  • Early Career

NIH Funding · FY2024

Total Funding
$1M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#15,004
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1M across 4 grants · National rank #15004.

Top grants by award amount

Kexin Xu's NIH grant portfolio, ranked by award amount.

  • 1R01CA279681-01A1R01
    Function of the METTL3-NUP93 complex-mediated nuclear export of m6A-modified mRNAs in castration-resistant prostate cancer.
    $440K
    award amount
  • 7R01GM140084-05R01
    METTL3-NUP93 interaction facilitates the nuclear export of m6A-modified mRNAs
    $347.2K
    award amount
  • 7R21CA277399-02R21
    Development of a new class of EZH2 inhibitors in ERa-negative breast cancer
    $126.5K
    award amount
  • 1R21CA277399-01A1R21
    Development of a new class of EZH2 inhibitors in ERa-negative breast cancer.
    $86.7K
    award amount

Affiliations

Institutions that have administered grants for Kexin Xu.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    UT Health Science Center Houston
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Multi-Institutional Research
    Awards at 2 institutions